Tellier G , Lenne A , Cailliau-Maggio K , Cabezas-Cruz A , Valdés JJ , Martoriati A , Aliouat el M , Gosset P , Delaire B , Fréville A , Pierrot C , Khalife J .

	Figure 1. Molecular cloning, sequences analysis of PfeIF2β and its expression by P. falciparum. (A) Analysis of P. falciparum (PF3D7_1010600) and human eIF2β (GenBank AAA52383.1). Sequences were aligned using ClustalW Multiple Alignment (BioEdit). The identical and semiconserved amino acids are highlighted in black and gray respectively. Lysine blocks and GTP binding domains are underlined with orange and blue lines respectively. Green line corresponds to the domain of the superfamily eIF2/eIF5. The blue boxes contain the ≪zinc finger≫ motif (C2-C2motif). The potential PP1-binding motifs “RVxF” and “FxxR/KxR/K” are in red and green boxes respectively. Phosphorylable amino acids reported in PlasmoDB are in red. (B) Detection of endogenous PfeIF2β in asynchronous cultures of P. falciparum. Blots were probed with pre-immune serum (lane 1) or with anti-PfeIF2β serum (lane 2). The blots were revealed as described in Section Materials and Methods.
	Figure 2. Phylogenetic position and relevant domains of eIF2β from Apicomplexan parasites. (A) The figure displays the maximum likelihood phylogenetic tree of eIF2β amino acid sequences from 23 apicomplexan, 5 mammals, 1 amphibian, 8 fish, 9 plants, 8 arthropods, 12 archaea, 1 yeast (fungi), 2 amoebozoa, 1 cercozoa, 1 foraminifera, and 5 excavata. All sequences selected for the analysis belonged to eIF5/eIF2B family (pfam01873), and contained the characteristic eIF2B domain (Accession number: PRK03988). The position eIF2β from P. falciparum is shown (red branch and circle). Numerals at internal branches represent bootstrap values. Only bootstrap values higher than 50 are shown. The accession number of each sequence is provided in the figure. The name of species was abbreviated as follow: Apicomplexan: Pfal, Plasmodium falciparum; Pber, P. berghei; Pkno, P. knowlesi; Pviv, P. vivax; Pyyo, P. yoelii yoelii; Prei, P. reichenowi; Pcyn, P. cynomolgi; Pinu, P. inui; Pvvi, P. vinckei vinckei; Bequ, Babesia equi; Bbig, B. bigemina; Bmic, B. microtis; Bbov, B. bovis; Tann, Theileria annulata; Tori, T. orientalis; Tpar, T. parva; Hham, Hammondia hammondi; Eace, Eimeria acervulina; Ncan, Neospora caninum; Cpar, Cryptosporidium parvum; Cmur, C. muris; Tgon, Toxoplasma gondii; and Gnip, Gregarina niphandrodes; Mammals: Hsap, Homo sapiens; Mmus, Mus musculus; Btau, Bos taurus; Ggor, Gorilla gorilla; Cfer, Camelus ferus; Amphibian: Xlae, Xenopus laevis; Fish: Drer, Danio rerio; Ssal, Salmo salar; Eluc, Esox Lucius; Omyk, Oncorhynchus mykiss; Locu, Lepisosteus oculatus; Spar, Stegastes partitus; Csem, Cynoglossus semilaevis; Nbri, Neolamprologus brichardi; Plant: Atha, Arabidopsis thaliana; Pvul, Phaseolus vulgaris; Csat, Cucumis sativus; Sind, Sesamum indicum; Csat, Camelina sativa; Vvin, Vitis vinifera; Ptri, Populus trichocarpa; Peu, Populus euphratica; Brap, Brassica rapa; Insects: Drosophila melanogaster; Ccap, Ceratitis capitata; Bdor, Bactrocera dorsalis; Adar, Anopheles darling; Asin, A. sinensis; Agam, A. gambiae; Mdom, Musca domestica; Nvit, Nasonia vitripennis; Archeae: Nequ, Nanoarchaeum equitans; Ssol, Sulfolobus solfataricus; PNA2, Pyrococcus sp. NA2; TES1, Thermococcus sp. ES1; Tbar, T. barophilus; Tgam, T. gammatolerans EJ3; Paby, Pyrococcus abyssi GE5; Pyay, P. yayanosii CH1; Pfur, P. furiosus; Mvan, Methanococcus vannielii SB; Mkan, Methanopyrus kandleri AV19; Smar, Staphylothermus marinus F1; and the Fungi: Spom, Schizosaccharomyces pombe; Amoebozoa: Edis, Entamoeba dispar; Ehis, Entomoeba histolytica; Cercozoa: Pbra, Plasmodiophora brassicae; Foraminifera: Rfil, Reticulomyxa filose and Excavata: Tviv, Trypanosoma vivax; Tgra, T. grayi; Tbb, T. brucei brucei; Tbg, T. brucei gambiense; Tcru, T. cruzi. The accession number of each sequence is provided in Table S2. (B) Simplified representation of eIF2β sequence for each group in the tree. Data regarding functional domains was collected from Asano et al. (1999) and Fréville et al. (2014).
	Figure 3. Modeling of the tertiary structure of PfeIF2β. (A) The figure shows the tertiary structure for the initiation factor of P. falciparum (predicted model) based on the initiation factor of Pyrococcus furiosus (PDB: 2DCU, chain B) in 180 turns. The structure is color-coded from the N-terminus (blue) to the C-terminus (red). The helix-turn-helix (HTH) and the zinc-binding domain (ZBD) are indicated (colored according to the respective position). The zinc ion is represented as a gray sphere. (B) The panel is a superposition of the alpha-carbon backbone of both structures (RMSD = 2.3à ).
	Figure 4. Interaction between PfeIF2β and its partners PfeIF2γ and PfeIF5. (A) GST pull-down assays. Glutathione beads alone (lane 1) or coupled with GST alone (lane 2), or GST-PfeIF2γ (lane 3) were incubated with 6His-tagged PfeIF2β wild-type. After washings, proteins bound to the beads were separated by SDS-PAGE and blotted to nitrocellulose. Immunoblot (IB) analysis was performed with mAb anti-His antibodies (upper blot) and mAb anti-GST (lower blot). As control, 20% of the input of PfeIF2β protein detected was used and immunoblotted with anti-His antibody (lane 4). (B) Interaction of PfeIF2β with PfeIF2γ in Xenopus oocytes. His-tagged PfeIF2γ recombinant protein and cRNA of PfeIF2β producing HA-tagged protein were micro-injected in fresh oocytes. Co-immunoprecipitations were carried out with anti-His (recognizing recombinant PfeIF2γ tagged with 6-His) (upper blot) or with anti-HA (recognizing PfeIF2β tagged HA) (lower blot) antibodies from micro-injected Xenopus extracts. Immunoprecipitates from Xenopus oocytes micro-injected with cRNA PfeIF2β alone (lane 1), PfeIF2γ protein alone (lane 2), or PfeIF2β and PfeIF2γ (lane 3) were eluted, separated by SDS-PAGE and transferred to nitrocellulose membrane. Immunoblot (IB) analysis was performed with anti-His or anti-HA antibodies. (C) Interaction of PfeIF2β with PfeIF5. His-tagged PfeIF2β recombinant protein and cRNA of PfeIF5 producing HA-tagged protein were micro-injected in fresh oocytes. Co-immunoprecipitations were performed as described in (B). Immunoprecipitates (IP) from Xenopus oocytes micro-injected with PfeIF5 cRNA alone (lane 1), PfeIF2β protein alone (lane 2), or PfeIF2β and PfeIF5 cRNA (lane 3) were eluted, separated by SDS-PAGE and transferred to nitrocellulose membrane. Immunoblots were performed as described in (B).
	Figure 5. Interaction studies of PfeIF2β with PfPP1. (A) Binding of His-tagged PfPP1 recombinant protein to endogenous PfeIF2β expressed by P. falciparum. Total soluble proteins extracted from asynchronous cultures (2 mg) were pre-cleared on Ni-NTA-agarose beads before and incubated overnight with PfPP1-6His affinity Ni-NTA column. After washings, eluted proteins were separated by SDS-PAGE and blotted onto nitrocellulose. Using anti-His mAb, lane 1 confirmed the presence of His-PP1. Pre-immune serum and anti-PfeIF2β antisera were used in lanes 2 and 3 respectively. Lane 3 showed the presence of PfeIF2β. As positive control, the presence of PfeIF2β in the total parasite extracts using the PfeIF2β antisera is shown in lane 4. (B) Direct binding of PfeIF2β to PfPP1 by GST pull-down assays. Glutathione beads alone (lane 1) or coupled with GST alone (lane 2), or PfPP1-GST (lane 3) were incubated with 6His-tagged PfeIF2β wild-type. After washings, proteins bound to the beads were separated by SDS-PAGE and blotted onto nitrocellulose. Immunoblot analysis was performed with anti-His mAb (upper blot) and anti-GST mAb (lower blot). (C) Scheme representing the different versions of PfeIF2β recombinant proteins (wild-type or mutated) used in this study. (D) Mapping of PfeIF2β binding motifs to PfPP1. Glutathione agarose beads coupled with GST alone (lanes 1, 3, 5, 7, and 9), or GST-PfPP1 (lanes 2, 4, 6, 8, 10) were incubated with 6His-tagged PfeIF2β wild-type (lanes 3 and 4), or PfeIF2β 103KAAA106 (lanes 5 and 6), or PfeIF2β 29AGEAKA34 (lanes 7 and 8), or PfeIF2β 103KAAA106/29AGEAKA34 (lanes 9 and 10). After washings, proteins bound to the beads were separated by SDS-PAGE and blotted to nitrocellulose. Immunoblot analysis was performed with anti-GST mAb (upper blot) and with anti-His mAb (lower blot). The inputs represent 0.5 μg of each 6His-tagged protein (lanes 11, 12, 13, and 14).
	Figure 6. Effect of PfeIF2β on GVBD induction in Xenopus oocytes. (A) Induction of Germinal Vesicle Break Down (GVBD) in Xenopus oocytes by PfeIF2β. Each oocyte was micro-injected with 60 ng of PfeIF2β wild-type, or PfeIF2β 103KAAA106, or PfeIF2β 29AGEAKA34, or PfeIF2β 103KAAA106/29AGEAKA34 recombinant protein. Appearance of GVBD was monitored 15 h after injection. Each experiment was performed using a set of 20 oocytes. Results are presented as percentage ± SEM of four independent experiments (20 oocytes for each protein). (B) Binding of PfeIF2β to Xenopus oocytes PP1. Co-immunoprecipitation experiments with anti-His (upper blot) or anti-XePP1 (lower blot) antibodies were carried out on extracts obtained from oocytes micro-injected with wild-type, single mutated, or double mutated proteins. The anti-mouse IgG antibody was used as a control. Immunoprecipitates from oocytes were eluted, separated by SDS-PAGE and transferred to a nitrocellulose membrane. Immunoblot analysis was performed with anti-His antibodies (recognizing PfeIF2β) or anti-XePP1 antibodies.
	Figure 7. Targeted gene disruption of the PfeIF2β locus. (A) Gene-targeting construct for gene disruption by single homologous recombination using pCAM-BSD, and the locus resulting from integration of the Knock-Out construct. (B) Analysis of pCAM-BSD-PfeIF2β-transfected 3D7 cultures by PCR; lanes 1–3 correspond to DNA extracted from wild-type parasites; lanes 4–6 correspond to DNA extracted from transfected parasites. Lanes 1 and 4 represent the detection of the full-length wild-type locus (PCR with p25 and p28); lanes 2 and 5 represent the detection of episomal DNA (PCR with p29 and p30); lanes 3 and 6 represent the detection of integration of the insert (PCR with p24 and p30). The absence of a PCR product in lane 6 indicates the lack of homologous integration.
	Figure 8. HA-tagging of the PfeIF2β locus. (A) Epitope tagging of PfeIF2β by Knock-In strategy. Insertion of an HA epitope tag at the C-terminus of PfeIF2β single homologous recombination. (B) Analysis of pCAM-BSD-HA-PfeIF2β-transfected 3D7 cultures by PCR; lanes 1–2 correspond to DNA extracted from wild type parasites; lanes 3–4 correspond to DNA extracted from transfected parasites. Lanes 1 and 3 represent the detection of the wild-type locus (PCR with p25 and p28); lanes 2 and 4 represent the detection of integration at the 5′ end of the insert (PCR with p24 and p31). The presence of a PCR product (arrow) and its sequencing confirmed the integration of a tagged HA-PfeiF2b gene in the locus. (C) Expression of HA-PfeIF2β was checked by Western-blot with anti-HA-biotin antibody after separation on SDS-PAGE. Lane 1 represents the culture of wild-type parasites and lane 2 represents the culture of transfected parasites.
	Figure 9. Localization of PfeIF2β. (A) Immunolocalization assays. Asynchronous cultures of PfeIF2β-HA tag recombinant strain of P. falciparum 3D7 were fixed with formalin and paraffin embedded. Sections were incubated with an anti-HA tag (biotin) antibody recognized by a streptavidine-Alexa fluor 488-labeled conjugated added with DAPI to label nuclei. Fluorescence staining was analyzed using a Zeiss LSM880 confocal microscope. The merged image of the double stained (PfeIF2β-HA tag, DAPI) and differential interference contrast (DIC) images are also presented. Immunofluorescence assays revealed a cytoplasmic localization of PfeIF2β in the trophozoite (panel 1), young schizont (panel 2), or mature schizont (panel 3) stages. Note that no staining was observed in ring-stage. No staining was observed when the primary antibody (anti-HA) was omitted (not shown). Bar = 5 μm. (B) Immunoblot analysis on nuclear and cytoplasm fractions from asynchronous parasites cultures. The quality control of nuclear (N) and cytoplasm (C) fractions were checked using Anti-SOD1 (upper panel) and anti-H3 antibodies (middle panel) respectively. The (lower) panel showed the presence of PfeIF2β in both fractions. (C) A representative Western blot assay showing the detection of PfeIF2β in cytoplasm and nuclear extracts (upper panel) from ring-stage (R), trophozoit-stage (T), and schizont-stage (S). Equal amount of nuclear and cytoplasmic proteins (10 μg) extracted from each stage were loaded. The (lower) panel showed the detection of Pf-actin 1 in the different nuclear and cytoplasmic fractions used.

Adl, The revised classification of eukaryotes. 2012, Pubmed

Adl, The revised classification of eukaryotes. 2012, Pubmed
Aggen, Regulation of protein phosphatase-1. 2000, Pubmed
Asano, Conserved bipartite motifs in yeast eIF5 and eIF2Bepsilon, GTPase-activating and GDP-GTP exchange factors in translation initiation, mediate binding to their common substrate eIF2. 1999, Pubmed
Berjanskii, Resolution-by-proxy: a simple measure for assessing and comparing the overall quality of NMR protein structures. 2012, Pubmed
Bhattacharyya, Plasmodium falciparum protein phosphatase type 1 functionally complements a glc7 mutant in Saccharomyces cerevisiae. 2002, Pubmed
Bohnsack, Exp5 exports eEF1A via tRNA from nuclei and synergizes with other transport pathways to confine translation to the cytoplasm. 2002, Pubmed
Bollen, Combinatorial control of protein phosphatase-1. 2001, Pubmed
Bollen, The extended PP1 toolkit: designed to create specificity. 2010, Pubmed
Burchard, [Malaria]. 2014, Pubmed
Castresana, Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. 2000, Pubmed
Ceulemans, Functional diversity of protein phosphatase-1, a cellular economizer and reset button. 2004, Pubmed
Daher, A Toxoplasma gondii leucine-rich repeat protein binds phosphatase type 1 protein and negatively regulates its activity. 2007, Pubmed , Xenbase
Daher, Census, molecular characterization and developmental expression of Leucine-Rich-Repeat proteins in Plasmodium falciparum. 2007, Pubmed
Daher, Plasmodium falciparum dynein light chain 1 interacts with actin/myosin during blood stage development. 2010, Pubmed
Daher, Regulation of protein phosphatase type 1 and cell cycle progression by PfLRR1, a novel leucine-rich repeat protein of the human malaria parasite Plasmodium falciparum. 2006, Pubmed , Xenbase
Das, Mutational analysis of mammalian translation initiation factor 5 (eIF5): role of interaction between the beta subunit of eIF2 and eIF5 in eIF5 function in vitro and in vivo. 2000, Pubmed
Das, Specific interaction of eukaryotic translation initiation factor 5 (eIF5) with the beta-subunit of eIF2. 1997, Pubmed
Doerig, Targeting kinases in Plasmodium and Schistosoma: Same goals, different challenges. 2015, Pubmed
Fardilha, The physiological relevance of protein phosphatase 1 and its interacting proteins to health and disease. 2010, Pubmed
Finn, Pfam: the protein families database. 2014, Pubmed
Foth, Quantitative time-course profiling of parasite and host cell proteins in the human malaria parasite Plasmodium falciparum. 2011, Pubmed
Fréville, Identification of a Plasmodium falciparum inhibitor-2 motif involved in the binding and regulation activity of protein phosphatase type 1. 2014, Pubmed , Xenbase
Fréville, Plasmodium falciparum inhibitor-3 homolog increases protein phosphatase type 1 activity and is essential for parasitic survival. 2012, Pubmed
Fréville, Plasmodium falciparum encodes a conserved active inhibitor-2 for Protein Phosphatase type 1: perspectives for novel anti-plasmodial therapy. 2013, Pubmed , Xenbase
Gallego, Protein serine/threonine phosphatases: life, death, and sleeping. 2005, Pubmed
Gutiérrez, Zinc is required for structural stability of the C-terminus of archaeal translation initiation factor aIF2beta. 2002, Pubmed
Gutiérrez, Structure of the archaeal translation initiation factor aIF2 beta from Methanobacterium thermoautotrophicum: implications for translation initiation. 2004, Pubmed
Guttery, Genome-wide functional analysis of Plasmodium protein phosphatases reveals key regulators of parasite development and differentiation. 2014, Pubmed
Guttery, Commit and Transmit: Molecular Players in Plasmodium Sexual Development and Zygote Differentiation. 2015, Pubmed
Hashimoto, Translation initiation at non-AUG codons mediated by weakened association of eukaryotic initiation factor (eIF) 2 subunits. 2002, Pubmed
Heaney, Deletion of eIF2beta suppresses testicular cancer incidence and causes recessive lethality in agouti-yellow mice. 2009, Pubmed
Hendrickx, Docking motif-guided mapping of the interactome of protein phosphatase-1. 2009, Pubmed
Heroes, The PP1 binding code: a molecular-lego strategy that governs specificity. 2013, Pubmed
Holm, Dali server: conservation mapping in 3D. 2010, Pubmed
Jones, The rapid generation of mutation data matrices from protein sequences. 1992, Pubmed
Katoh, MAFFT multiple sequence alignment software version 7: improvements in performance and usability. 2013, Pubmed
Laurino, The beta subunit of eukaryotic translation initiation factor 2 binds mRNA through the lysine repeats and a region comprising the C2-C2 motif. 1999, Pubmed
Llorens, The N-terminal domain of the human eIF2beta subunit and the CK2 phosphorylation sites are required for its function. 2006, Pubmed
Marchler-Bauer, CDD: NCBI's conserved domain database. 2015, Pubmed
Neafsey, Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. 2015, Pubmed
Nguyen Ba, NLStradamus: a simple Hidden Markov Model for nuclear localization signal prediction. 2009, Pubmed
Oehring, Organellar proteomics reveals hundreds of novel nuclear proteins in the malaria parasite Plasmodium falciparum. 2012, Pubmed
Pease, Global analysis of protein expression and phosphorylation of three stages of Plasmodium falciparum intraerythrocytic development. 2013, Pubmed
Richie, Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. 2015, Pubmed
RTS,S Clinical Trials Partnership, Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. 2015, Pubmed
Sidhu, pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. 2005, Pubmed
Sokabe, Structure of archaeal translational initiation factor 2 betagamma-GDP reveals significant conformational change of the beta-subunit and switch 1 region. 2006, Pubmed
Solyakov, Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum. 2011, Pubmed
Tamura, MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. 2013, Pubmed
Tewari, The systematic functional analysis of Plasmodium protein kinases identifies essential regulators of mosquito transmission. 2010, Pubmed
Thompson, Conserved sequences in the beta subunit of archaeal and eukaryal translation initiation factor 2 (eIF2), absent from eIF5, mediate interaction with eIF2gamma. 2000, Pubmed
Ting, DNA-dependent protein kinase interacts with antigen receptor response element binding proteins NF90 and NF45. 1998, Pubmed
Trager, Human malaria parasites in continuous culture. 1976, Pubmed
Umlas, New thick-film technique for malaria diagnosis. Use of saponin stromatolytic solution for lysis. 1971, Pubmed
Vandomme, PhosphoTyrosyl phosphatase activator of Plasmodium falciparum: identification of its residues involved in binding to and activation of PP2A. 2014, Pubmed , Xenbase
van Dooren, Development of the endoplasmic reticulum, mitochondrion and apicoplast during the asexual life cycle of Plasmodium falciparum. 2005, Pubmed
Vernes, Plasmodium falciparum strain-specific human antibody inhibits merozoite invasion of erythrocytes. 1984, Pubmed
Vicogne, Conservation of epidermal growth factor receptor function in the human parasitic helminth Schistosoma mansoni. 2004, Pubmed , Xenbase
Voss, Plasmodium falciparum possesses a cell cycle-regulated short type replication protein A large subunit encoded by an unusual transcript. 2002, Pubmed
Wakula, The translation initiation factor eIF2beta is an interactor of protein phosphatase-1. 2006, Pubmed
Yatime, Structure of an archaeal heterotrimeric initiation factor 2 reveals a nucleotide state between the GTP and the GDP states. 2007, Pubmed